EFPIA - NEWSLETTER

EFPIA Newsletter 21 February 2019

News

20 February 2019 Heading towards value-based healthcare

How measuring outcomes leads to better patients’ health and sustainable health systems

Videos

EFPIA Manifesto: Building a healthier future for Europe

We have a vision for a healthier world. We can see a brighter tomorrow for all patients. #WeWontRest until we get there.
Read the full EFPIA Manifesto here.

Health For All: Bringing innovative health solutions to all patients

#WeWontRest until we bring innovative health solutions to all patients.
Read the full EFPIA Manifesto here.

Events

06 MAR 2019

EU Ecosystem For Monitoring Of Post-Licensure Vaccine Benefit And Risk: From ADVANCE... Brussels

An IMI's multi stakeholder conference

Learn more →

08 MAY 2019

2019 China/EU Pharmaceutical Industry Forum Hangzhou, China

The workshop covers 4 different themes: Pharmaceuticals in the Environment, Pricing & Reimbursement, Compliance (marketing...

Learn more →

What we are reading

PATIENT VALUE: Adoption of patient-centred care by health systems globally 21 February 2019 (The Economist Intelligence Unit)

SPC waiver stockpiling provision attracts criticism 19 February 2019 (Life Sciences Intellectual Property Review)

What are Brexit contingency plans for pharmaceutical industry? 19 February 2019 (The Guardian)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶